Balversa - bulk
Ended Awarded Last action
- Contract number
- 36C26025F0018
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$211,720 | |
| Original award | $211,720 |
About this award
This federal contract award to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., is for the delivery of BALVERSA (erdafitinib), a cancer treatment drug, to the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $211,719.96 and a period of performance through September 30, 2025.
Janssen Biotech holds two significant federal contract Indefinite Delivery Vehicles (IDVs) with the VA - a $3.7 million Blanket Purchase Agreement (BPA) and a $3.1 billion Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. These IDVs enable various Veterans Integrated Service Networks (VISNs) to efficiently procure a wide range of pharmaceutical products, including BALVERSA and other oncology medications, to support comprehensive healthcare services for veterans across the country. The contract award does not have a set-aside designation, reflecting Janssen Biotech's status as a large, for-profit pharmaceutical manufacturer.
Quick answers
Who was awarded contract 36C26025F0018?
36C26025F0018 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26025F0018 worth?
The government has obligated $0 on 36C26025F0018.
Is contract 36C26025F0018 an order under another contract?
Yes. 36C26025F0018 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0018 competed?
The extent of competition for 36C26025F0018 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award